Feedback / Questions
frevecitinib (KN-002) - Kinaset Therap
https://www.businesswire.com/news/home/20260110058494/en/Kinaset-Therapeutics-Announces-%24103-Million-Oversubscribed-Series-B-Financing-to-Advance-Novel-Inhaled-Therapeutic-Candidate-for-Respiratory-Diseases
Jan 10, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next